Mind Medicine (MindMed) (MNMD) Stock Forecast & Price Target

MNMD$20.69+0.09 +0.44%
Biotechnology
Compare
Market cap$1.56BEnterprise value$1.32BRevenue (TTM)$0Market position—

Score

38
Bearish
Value
48
Quality
51
Growth
16

Mind Medicine (MindMed) Inc. price target

MNMD
Low$14.00
Average$20.00
High$28.00
Upside vs current price-3.3%

The average target of $20.00 is -3.3% versus the current MNMD price of $20.69.

Mind Medicine (MindMed) Inc. analyst ratings

RatingAnalysts
Strong buy0
Buy1
Hold0
Sell0
Strong sell0
ConsensusBuy

1 analyst covers MNMD.

Mind Medicine (MindMed) Inc. EPS and revenue estimates

MNMD shows the next fiscal years with at least three analysts: 2026 EPS $-3.01, 2027 EPS $-1.76. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-3.01$16.67M
2027$-1.76$28.45M

Is Mind Medicine (MindMed) Inc. a buy or sell?

Of the 1 analyst covering Mind Medicine (MindMed) Inc., 1 rates it a buy (0 strong buy and 1 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The MNMD consensus label is Buy, beside 1 buy-side ratings and 0 sell-side ratings.

The average target of $20.00 implies -3.3% versus the current price of $20.69.

Those 1 ratings on MNMD are a headcount, and the label on file is Buy.

Reading the Mind Medicine (MindMed) Inc. forecast

The MNMD target range is wide: $14.00 at the low end, $20.00 in the middle, and $28.00 at the top.

Set next to the $20.69 MNMD quote, that average is -3.3%.

Ratings on the Mind Medicine (MindMed) Inc. cluster: 1 of 1 analyst is on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

The MNMD EPS path from 2026 ($-3.01) to 2027 ($-1.76) is rising.

Only 1 analyst covers MNMD, so the average rests on a short list.

Mind Medicine (MindMed) Inc. forecast questions

What is the MNMD price target?

The published range for MNMD is $14.00 to $28.00, with an average of $20.00. That average is -3.3% versus the current price of $20.69.

Is Mind Medicine (MindMed) Inc. a buy or sell?

Of the 1 analyst covering Mind Medicine (MindMed) Inc., 1 rates it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the MNMD headcount is 1 buy, 0 hold, and 0 sell.

What is the EPS estimate for Mind Medicine (MindMed) Inc.?

Analyst EPS estimates for Mind Medicine (MindMed) Inc.: 2026 $-3.01, 2027 $-1.76.

What is the revenue estimate for Mind Medicine (MindMed) Inc.?

Analyst revenue estimates for Mind Medicine (MindMed) Inc.: 2026 $16.67M, 2027 $28.45M.

How many analysts cover MNMD?

1 analyst covers MNMD. Their consensus on MNMD is Buy, across those 1.

MNMD price $20.69 +0.09 +0.44%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener